FIELD: medicine, psychiatry.
SUBSTANCE: invention relates, in particular, to psychopharmacology of bordering psychic disorders. The preparation "Mielopid" is administrated in body by intramuscular route in the dose 3.0 mg, 1 time per 24 h, every day, for 5 days, amitriptylin in the dose 10-25 mg per 24 h and phenazepam in the dose 0.5-1.5 mg per 24 h. Method provides expanding assortment of agents used for treatment of patients with neurotic and somatoformic disorders, to reduce adverse effects of psychopharmtherapy and period for treatment.
EFFECT: improved method for treatment.
3 tbl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| EARLY DIAGNOSTIC TECHNIQUE FOR CLINICAL COURSE AND OUTCOME OF NEUROTIC, STRESS-RELATED CONNECTED WITH STRESS, SOMATOFORM AND NEUROSIS-LIKE DISORDERS | 2009 |
|
RU2427841C2 |
| METHOD OF NEUROSISES AND PSYCHOEMOTIONAL DISORDERS TREATMENT | 2008 |
|
RU2365365C1 |
| METHOD OF RELIEVING RESISTANT OBSESSIVE-PHOBIC SYNDROME OF ENDOGENOUS GENESIS AND RESISTANT SENESTO-HYPOCHONDRIAC SYNDROME OF ENDOGENOUS GENESIS | 2018 |
|
RU2696683C1 |
| METHOD TO CORRECT IMMUNE DISORDERS AT OPIUM NARCOMANIA | 2000 |
|
RU2183125C1 |
| METHOD OF PHARMACOTHERAPY OF PANIC DISORDER | 2011 |
|
RU2452486C1 |
| CONSTITUTIONAL APPROACH TO CUPPING OFF PSYCHOGENIC NONPSYCHOTIC-LEVEL PSYCHOPATHOLOGIC SYNDROMES IN TERRORISM VICTIMS AND HOSTAGES | 1999 |
|
RU2161968C1 |
| METHOD FOR TREATING ASTHENIC DISORDERS DUE TO APPLYING "HALAVIT" PREPARATION | 2005 |
|
RU2319485C2 |
| METHOD OF LOW-INTENSIVE LASER THERAPY OF NEUROTIC DISORDERS | 2009 |
|
RU2440161C2 |
| USE OF METHYL ETHER OF N-CAPROYL-L-PROLYL-L-TYROSINE (DILEPT) AS AGENT WITH PSYCHOSTIMULANT ACTIVITY | 2015 |
|
RU2593886C1 |
| COMBINATION AND KIT WITH ANXIOLYTIC ACTION | 2017 |
|
RU2703729C2 |
